ProShares UltraShort Nasdaq Biotechnology (BIS)
| Assets | $2.58M |
| Expense Ratio | 0.95% |
| PE Ratio | n/a |
| Shares Out | 171,096 |
| Dividend (ttm) | $0.60 |
| Dividend Yield | 3.76% |
| Ex-Dividend Date | Jun 25, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| Volume | 15,938 |
| Open | 15.85 |
| Previous Close | 15.89 |
| Day's Range | 15.85 - 16.16 |
| 52-Week Low | 14.05 |
| 52-Week High | 25.87 |
| Beta | -1.27 |
| Holdings | 6 |
| Inception Date | Apr 8, 2010 |
About BIS
Fund Home PageThe ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 25, 2025 | $0.10805 | Jul 1, 2025 |
| Mar 26, 2025 | $0.13255 | Apr 1, 2025 |
| Dec 23, 2024 | $0.20639 | Dec 31, 2024 |
| Sep 25, 2024 | $0.15181 | Oct 2, 2024 |
| Jun 26, 2024 | $0.16119 | Jul 3, 2024 |
| Mar 20, 2024 | $0.15859 | Mar 27, 2024 |
Performance
BIS had a total return of 1.78% in the past year, including dividends. Since the fund's inception, the average annual return has been -30.71%.
News
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.